Skip to content

Health Catalyst HCAT Common Stock Shares Authorized

Other financials

Income statement

See full
Revenue$70.8M-10.9%
Gross profit$35.5M-2.1%
Operating income-$106.5M-428%
Net income-$111.0M-368%
EPS (diluted)-$1.53-337%

Balance sheet

See full
Cash & equivalents$59.9M-82.5%
Total debt$170.6M-57.6%
Total equity$138.1M-63.3%
Total assets$412.2M-53.8%

Cash flow

See full
Operating cash flow$18.5M+6,511%
CapEx$338.0K-49.6%
Free cash flow$18.2M+4,760%

Valuation

See full
Market cap$147.05M-43.6%
Enterprise value$257.76M-32.7%
P/S0.5×-0.3×

Profitability

See full
Gross margin49.9%+4.7pp
Operating margin-81.7%-127pp
Net margin-87.7%-138pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-103%-135pp
Debt / equity1.2×+0.2×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by Health Catalyst in its filing.

Tagged under the XBRL concept us-gaap:SharesOutstanding.

The official record: Health Catalyst’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Health Catalyst's common stock shares authorized.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Health Catalyst's common stock shares authorized?
Health Catalyst (HCAT) reported common stock shares authorized of 73.9M in Q1 2026.
How has Health Catalyst's common stock shares authorized changed year-over-year?
Health Catalyst's common stock shares authorized increased by 6.1% year-over-year, from 69.6M to 73.9M.
What is the long-term trend for Health Catalyst's common stock shares authorized?
Over 5 years (2020 to 2025), Health Catalyst's common stock shares authorized has grown at a 10.5% compound annual growth rate (CAGR), from 43.7M to 72.1M.